Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 9/2023

16.03.2023

Antero-lateral vs. antero-posterior electrode position for cardioversion of atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials

verfasst von: Zain Ul Abideen Asad, Sana Imran, Miloni Parmar, Awais Bajwa, Derek Truong, Siddharth Agarwal, Asad Ghani, Shari Clifton, Jessica Reese, Muhammad Shahzeb Khan, Muhammad Bilal Munir, Christopher V. DeSimone, Chittur Sivaram, Warren M. Jackman, Sunny Po, Stavros Stavrakis, Sana M. Al-Khatib

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Multiple randomized controlled trials (RCTs) have compared the success of antero-lateral vs. antero-posterior electrode position for cardioversion of atrial fibrillation (AF). However, due to small sample size and conflicting results of these RCTs, the optimal electrode positioning for successful cardioversion remains uncertain.

Methods

A systematic search of MEDLINE and EMBASE was conducted. Outcomes of interest included overall success of cardioversion with restoration of sinus rhythm, 1st shock success, 2nd shock success, mean shock energy required for successful cardioversion, mean number of shocks required for successful cardioversion, success of cardioversion at high energy (> 150 J) and success of cardioversion at low energy (< 150 J). Mantel–Haenszel risk ratios (RR) with 95% confidence intervals were calculated using random-effects model.

Results

A total of 14 RCTs comprising 2445 patients were included. There was no statistically significant difference between two cardioversion approaches in the overall success of cardioversion (RR 1.02; 95% CI [0.97–1.06]; p = 0.43), first shock success (RR 1.14; 95% CI [0.99–1.32]), second shock success (RR 1.08; 95% CI [0.94–1.23]), mean shock energy required (mean difference 6.49; 95% CI [-17.33–30.31], success at high energy > 150 J (RR 1.02; 95% CI [0.92–1.14] and success at low energy < 150 J (RR 1.09; 95% CI [0.97–1.22]).

Conclusions

This meta-analysis of RCTs shows no significant difference in the success of cardioversion between antero-lateral vs. antero-posterior electrode position for cardioversion of AF. Large well-conducted and adequately powered randomized clinical trials are needed to definitively address this question.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Lown B, Neuman J, Amarasingham R, Berkovits BV. Comparison of alternating current with direct electroshock across the closed chest. Am J Cardiol. 1962;10:223–33.CrossRefPubMed Lown B, Neuman J, Amarasingham R, Berkovits BV. Comparison of alternating current with direct electroshock across the closed chest. Am J Cardiol. 1962;10:223–33.CrossRefPubMed
2.
Zurück zum Zitat Lown B, Amarasingham R, Neuman J. New method for terminating cardiac arrhythmias Use of ynchronized capacitor discharge. JAMA. 1962;182:548–55.PubMed Lown B, Amarasingham R, Neuman J. New method for terminating cardiac arrhythmias Use of ynchronized capacitor discharge. JAMA. 1962;182:548–55.PubMed
3.
Zurück zum Zitat Kirkland S, Stiell I, AlShawabkeh T, Campbell S, Dickinson G, Rowe BH. The efficacy of pad placement for electrical cardioversion of atrial fibrillation/flutter: a systematic review. Acad Emerg Med. 2014;21:717–26.CrossRefPubMed Kirkland S, Stiell I, AlShawabkeh T, Campbell S, Dickinson G, Rowe BH. The efficacy of pad placement for electrical cardioversion of atrial fibrillation/flutter: a systematic review. Acad Emerg Med. 2014;21:717–26.CrossRefPubMed
4.
Zurück zum Zitat Schmidt AS, Lauridsen KG, Møller DS, et al. Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation. Circ Am Heart Assoc. 2021;144:1995–2003. Schmidt AS, Lauridsen KG, Møller DS, et al. Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation. Circ Am Heart Assoc. 2021;144:1995–2003.
5.
Zurück zum Zitat Moher D. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Ann Intern Med. 2009;151:264.CrossRefPubMed Moher D. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Ann Intern Med. 2009;151:264.CrossRefPubMed
6.
Zurück zum Zitat Goutham R, Francisco L-J, Jack B, et al. Methodological Standards for Meta-Analyses and Qualitative Systematic Reviews of Cardiac Prevention and Treatment Studies: A Scientific Statement From the American Heart Association. Circ Am Heart Assoc. 2017;136:e172–94. Goutham R, Francisco L-J, Jack B, et al. Methodological Standards for Meta-Analyses and Qualitative Systematic Reviews of Cardiac Prevention and Treatment Studies: A Scientific Statement From the American Heart Association. Circ Am Heart Assoc. 2017;136:e172–94.
7.
Zurück zum Zitat Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. [Internet]. Available from: Available at www.covidence.org Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. [Internet]. Available from: Available at www.​covidence.​org
8.
Zurück zum Zitat Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.CrossRefPubMedPubMedCentral Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007;28:105–14.CrossRefPubMed DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007;28:105–14.CrossRefPubMed
10.
Zurück zum Zitat Botto GL, Politi A, Bonini W, Broffoni T, Bonatti R. External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements. Heart. 1999;82:726–30.CrossRefPubMedPubMedCentral Botto GL, Politi A, Bonini W, Broffoni T, Bonatti R. External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements. Heart. 1999;82:726–30.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Kirchhof P, Eckardt L, Loh P, et al. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. Lancet. 2002;360:1275–9.CrossRefPubMed Kirchhof P, Eckardt L, Loh P, et al. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. Lancet. 2002;360:1275–9.CrossRefPubMed
12.
Zurück zum Zitat Vogiatzis IA, Sachpekidis V, Vogiatzis IM, et al. External cardioversion of atrial fibrillation: the role of electrode position on cardioversion success. Int J Cardiol. 2009;137:e8-10.CrossRefPubMed Vogiatzis IA, Sachpekidis V, Vogiatzis IM, et al. External cardioversion of atrial fibrillation: the role of electrode position on cardioversion success. Int J Cardiol. 2009;137:e8-10.CrossRefPubMed
13.
Zurück zum Zitat Mathew T, Moore A, McIntyre M, et al. Randomised comparison of electrode positions for cardioversion of atrial fibrillation. Heart. 1999;81:576–9.CrossRefPubMedPubMedCentral Mathew T, Moore A, McIntyre M, et al. Randomised comparison of electrode positions for cardioversion of atrial fibrillation. Heart. 1999;81:576–9.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Kerber RE, Jensen SR, Grayzel J, Kennedy J, Hoyt R. Elective cardioversion: influence of paddle-electrode location and size on success rates and energy requirements. N Engl J Med. 1981;305:658–62.CrossRefPubMed Kerber RE, Jensen SR, Grayzel J, Kennedy J, Hoyt R. Elective cardioversion: influence of paddle-electrode location and size on success rates and energy requirements. N Engl J Med. 1981;305:658–62.CrossRefPubMed
15.
Zurück zum Zitat Risius T, Mortensen K, Schwemer TF, et al. Comparison of antero-lateral versus antero-posterior electrode position for biphasic external cardioversion of atrial flutter. Am J Cardiol. 2009;104:1547–50.CrossRefPubMed Risius T, Mortensen K, Schwemer TF, et al. Comparison of antero-lateral versus antero-posterior electrode position for biphasic external cardioversion of atrial flutter. Am J Cardiol. 2009;104:1547–50.CrossRefPubMed
16.
Zurück zum Zitat Walsh SJ, McCarty D, McClelland AJJ, et al. Impedance compensated biphasic waveforms for transthoracic cardioversion of atrial fibrillation: a multi-centre comparison of antero-apical and antero-posterior pad positions. Eur Heart J. 2005;26:1298–302.CrossRefPubMed Walsh SJ, McCarty D, McClelland AJJ, et al. Impedance compensated biphasic waveforms for transthoracic cardioversion of atrial fibrillation: a multi-centre comparison of antero-apical and antero-posterior pad positions. Eur Heart J. 2005;26:1298–302.CrossRefPubMed
17.
Zurück zum Zitat Brazdzionyte J, Babarskiene RM, Stanaitiene G. Anterior-posterior versus anterior-lateral electrode position for biphasic cardioversion of atrial fibrillation. Medicina (Kaunas). 2006;42:994–8.PubMed Brazdzionyte J, Babarskiene RM, Stanaitiene G. Anterior-posterior versus anterior-lateral electrode position for biphasic cardioversion of atrial fibrillation. Medicina (Kaunas). 2006;42:994–8.PubMed
18.
Zurück zum Zitat Siaplaouras S, Buob A, Rötter C, Böhm M, Jung J. Randomized comparison of anterolateral versus anteroposterior electrode position for biphasic external cardioversion of atrial fibrillation. Am Heart J. 2005;150:150–2.CrossRefPubMed Siaplaouras S, Buob A, Rötter C, Böhm M, Jung J. Randomized comparison of anterolateral versus anteroposterior electrode position for biphasic external cardioversion of atrial fibrillation. Am Heart J. 2005;150:150–2.CrossRefPubMed
19.
Zurück zum Zitat Alp NJ, Rahman S, Bell JA, Shahi M. Randomised comparison of antero-lateral versus antero-posterior paddle positions for DC cardioversion of persistent atrial fibrillation. Int J Cardiol. 2000;75:211–6.CrossRefPubMed Alp NJ, Rahman S, Bell JA, Shahi M. Randomised comparison of antero-lateral versus antero-posterior paddle positions for DC cardioversion of persistent atrial fibrillation. Int J Cardiol. 2000;75:211–6.CrossRefPubMed
20.
Zurück zum Zitat Boodhoo L, Mitchell ARJ, Bordoli G, Lloyd G, Patel N, Sulke N. DC cardioversion of persistent atrial fibrillation: a comparison of two protocols. Int J Cardiol. 2007;114:16–21.CrossRefPubMed Boodhoo L, Mitchell ARJ, Bordoli G, Lloyd G, Patel N, Sulke N. DC cardioversion of persistent atrial fibrillation: a comparison of two protocols. Int J Cardiol. 2007;114:16–21.CrossRefPubMed
21.
Zurück zum Zitat Chen C-J. Guo GB-F: External cardioversion in patients with persistent atrial fibrillation: a reappraisal of the effects of electrode pad position and transthoracic impedance on cardioversion success. Jpn Heart J. 2003;44:921–32.CrossRefPubMed Chen C-J. Guo GB-F: External cardioversion in patients with persistent atrial fibrillation: a reappraisal of the effects of electrode pad position and transthoracic impedance on cardioversion success. Jpn Heart J. 2003;44:921–32.CrossRefPubMed
22.
Zurück zum Zitat Stiell IG, Sivilotti MLA, Taljaard M, et al. Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial. The Lancet Elsevier. 2020;395:339–49.CrossRef Stiell IG, Sivilotti MLA, Taljaard M, et al. Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial. The Lancet Elsevier. 2020;395:339–49.CrossRef
23.
Zurück zum Zitat Risius T, Mortensen K, Schwemer TF, et al. Comparison of antero-lateral versus antero-posterior electrode position for biphasic external cardioversion of atrial flutter. Am J Cardiol. 2009;104:1547–50.CrossRefPubMed Risius T, Mortensen K, Schwemer TF, et al. Comparison of antero-lateral versus antero-posterior electrode position for biphasic external cardioversion of atrial flutter. Am J Cardiol. 2009;104:1547–50.CrossRefPubMed
24.
Zurück zum Zitat Botto GL, Politi A, Bonini W, Broffoni T, Bonatti R. External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements. Heart. 1999;82:726–30.CrossRefPubMedPubMedCentral Botto GL, Politi A, Bonini W, Broffoni T, Bonatti R. External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements. Heart. 1999;82:726–30.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Vogiatzis IA, Sachpekidis V, Vogiatzis IM, et al. External cardioversion of atrial fibrillation: the role of electrode position on cardioversion success. Int J Cardiol. 2009;137:e8-10.CrossRefPubMed Vogiatzis IA, Sachpekidis V, Vogiatzis IM, et al. External cardioversion of atrial fibrillation: the role of electrode position on cardioversion success. Int J Cardiol. 2009;137:e8-10.CrossRefPubMed
Metadaten
Titel
Antero-lateral vs. antero-posterior electrode position for cardioversion of atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials
verfasst von
Zain Ul Abideen Asad
Sana Imran
Miloni Parmar
Awais Bajwa
Derek Truong
Siddharth Agarwal
Asad Ghani
Shari Clifton
Jessica Reese
Muhammad Shahzeb Khan
Muhammad Bilal Munir
Christopher V. DeSimone
Chittur Sivaram
Warren M. Jackman
Sunny Po
Stavros Stavrakis
Sana M. Al-Khatib
Publikationsdatum
16.03.2023
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 9/2023
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-023-01523-x

Weitere Artikel der Ausgabe 9/2023

Journal of Interventional Cardiac Electrophysiology 9/2023 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.